Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...

A new study suggests that using weight loss drugs such as Ozempic and Wegovy can lead to less alcohol consumption. The study, ...

Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with ...

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

Hims & Hers offers a copycat of the blockbuster weight-loss drug at a fraction of the cost. But it might be a short-lived ...

The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating." ...

Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Both groups followed a reduced-calorie diet and exercise plan. Common side effects ... found in Mounjaro. While Zepbound is FDA-approved for weight loss, Mounjaro is approved for managing type ...

You must also follow a calorie-restricted diet and an exercise plan while using tirzepatide ... Tirzepatide is FDA-approved for weight loss as the brand-name drug Zepbound. It is also FDA-approved ...

She’s racing to a run-through for a 14-course tasting menu she will barely nibble at as she raves about her weight loss on Mounjaro. “Prime-time bikini weight is just 15 or 20 pounds away!” Jones, who ...

Novo also mentioned plans ... generation weight-loss drug” retatrutide, which targets three hormones: GLP-1, GIPR and glucagon. However, analysts have said that premilinary testing indicates the drug ...